Flavio A Amaral Selected Research

Flavio A Amaral Research Topics

5	Infections 02/2018 - 02/2009
4	Inflammation (Inflammations) 12/2020 - 09/2010
3	Arthritis (Polyarthritis) 06/2018 - 01/2015
2	Gout 12/2020 - 06/2018
1	Pain (Aches) 12/2020
1	Osteoarthritis 12/2020
1	Gouty Arthritis 12/2020
1	Edema (Dropsy) 12/2020
1	Synovitis 06/2018
1	Infectious Arthritis (Septic Arthritis) 02/2018
1	Sepsis (Septicemia) 09/2010
1	Severe Dengue 08/2009
1	Shock 08/2009
1	Thrombocytopenia (Thrombopenia) 08/2009
1	Hypotension (Low Blood Pressure) 08/2009
1	Hemorrhage 08/2009
1	Pneumonia (Pneumonitis) 02/2009
1	Respiratory Hypersensitivity 02/2009
1	Ischemia 12/2007
1	Reperfusion Injury 12/2007

6	CytokinesIBA 12/2020 - 08/2009
2	Uric Acid (Urate)IBA 12/2020 - 06/2018
2	AntigensIBA 01/2018 - 01/2015
2	ChemokinesIBA 01/2018 - 01/2018
2	Peptides (Polypeptides)IBA 01/2018 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009 - 12/2007
1	Interleukin-33IBA 12/2020
1	Superoxides (Superoxide)IBA 12/2020
1	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 06/2018
1	hesperidin methylchalconeIBA 06/2018
1	FlavonoidsIBA 06/2018
1	InflammasomesIBA 06/2018
1	GlycosaminoglycansIBA 01/2018
1	2'- ((4'- trifluoromethanesulfonyloxy)phenyl)- N- methanesulfonylpropionamideIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Chemotactic FactorsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 09/2010
1	EnzymesIBA 09/2010
1	Chemokine ReceptorsIBA 09/2010
1	Macrophage Migration-Inhibitory FactorsIBA 01/2010
1	Platelet Activating FactorIBA 08/2009
1	platelet activating factor receptorIBA 08/2009
1	Capsaicin (Zostrix)FDA Link 02/2009
1	lipoxin A4IBA 12/2007